RespireRx Pharmaceuticals Inc. Business Finance Contracts & Agreements
138 Contracts & Agreements
- Assignment Agreements (1 contract)
- Escrow Agreements (1)
- Exchange Agreements (16)
- Note Agreements (27)
- Purchase Agreements (24)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Stock Agreements (22)
- Subscription Agreements (2)
- Warrant Agreements (42)
- RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Warrant dated April 10, 2024 (Filed With SEC on April 16, 2024)
- RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Demand Promissory Note dated April 10, 2024 (Filed With SEC on April 16, 2024)
- RespireRx Demand Promissory Note and Warrant Purchase Agreement with Dariusz Nasiek and Sara Nasiek dated April 10, 2024 (Filed With SEC on April 16, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $54,000 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $40,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- Amended and Restated Convertible Note due January 30, 2025 in the amount of $85,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)
- RespireRx-Marc M. Radin PC Warrant dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx-Marc M. Radin PC Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx Demand Promissory Note and Warrant Purchase Agreement Marc M. Radin PC dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx-Arnold Lippa Family Trust of 2007 Warrant dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx-Arnold Lippa Family Trust of 2007 Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)
- RespireRx Demand Promissory Note and Warrant Purchase Agreement Arnold Lippa Family Trust of 2007 dated May 22, 2023 (Filed With SEC on May 24, 2023)
- Promissory Note template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms except as to... (Filed With SEC on November 17, 2022)
- Piggy-back Registrations Rights Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds,... (Filed With SEC on November 17, 2022)
- Securities Purchase Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms... (Filed With SEC on November 17, 2022)
- Common Stock Purchase Warrant, dated April 14, 2022 (Filed With SEC on April 15, 2022)
- Promissory Note dated, April 14, 2022 (Filed With SEC on April 15, 2022)
- Piggy-back Registration Rights Agreement dated April 14, 2022 between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)
- Securities Purchase Agreement dated April 14, 2022, between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)
- Escrow Deposit Agreement, dated October 23, 2020, between RespireRx Pharmaceuticals Inc. and Signature Bank (Filed With SEC on October 26, 2020)
- Amendment No. 1 to 8% Fixed Promissory Note, dated September 30, 2020 (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Patent Network Law Group (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Marc Radin PC (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Timothy Jones (Filed With SEC on October 14, 2020)
- Common Stock Purchase Warrant, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)
- 10% Convertible Note, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated July 30, 2020, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)
- 8% Fixed Promissory Note, dated July 28, 2020, in favor of White Lion Capital, LLC (Filed With SEC on October 14, 2020)
- Registration Rights Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)
- Equity Purchase Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)
- Fifth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)
- Fourth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)
- Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)
- Common Stock Purchase Warrant, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated July 2, 2020, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Convertible Promissory Note, dated June 7, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
